You just read:

The Market for Non-Small-Cell Lung Cancer (NSCLC) Will Grow to $7 Billion in 2022, Fuelled by the Entry of Twelve Novel Agents

News provided by

Decision Resources

Dec 12, 2013, 12:00 ET